CONTOUR®NEXT ONE meter will no longer be available to order from 14 June 2022. CONTOUR®NEXT test strips will continue to be available at your local pharmacy.
Learn more about the updated and fully compliant CONTOUR®NEXT connected meter.
Connecting the CONTOUR®NEXT ONE meter to the CONTOUR®DIABETES App may help you better understand9 your readings and support your blood glucose management.
Check to see if your smartphone’s operating system is compatible
ƒ95% of the measured glucose values needed to fall within either ±15 mg/dL (±0.83 mmol/L) of the average measured values of the reference measurement procedure at glucose concentrations <100 mg/dL (<5.55 mmol/L) or within ±15% at glucose concentrations ≥100 mg/dL (≥5.55 mmol/L). 99% of individual glucose measured values need to fall within zones A and B of the Consensus Error Grid (CEG) for type 1 diabetes.3
#Before use see the CONTOUR®NEXT ONE user guide for full instructions. †Always consult your healthcare professional before setting or changing any target ranges. ^On a compatible Android or iOS device. For a full list of compatible mobile operating systems, visit compatibility.contourone.com.
1. CONTOUR®NEXT ONE BGMS User Guide Rev 08/19. 2. Christiansen M et al. J Diabetes Sci Technol 2017;11(3):567-573. 3. International Organization for Standardization. In vitro diagnostic test systems –requirements for blood‐glucose monitoring systems for self‐testing in managing diabetes mellitus (ISO 15197). International Organization for Standardization, Geneva, Switzerland, 2013. 4. Stedman M et al. J Diabetes Sci Technol. 2020 Mar 14; doi: 10.1177/1932296820905880. Online ahead of print. 5. Campos-Nañez E, Breton MD. J Diabetes Sci Technol. 2017;11(6):1196-1206. 6. Al Hayek A et al. 27 Oct 2020. Patient Satisfaction and Clinical Efficacy of Novel Blood Glucose Meters Featuring Color Range Indicators in Patients With Type 2 Diabetes: A Prospective Study. Cureus 12(10): e11195. DOI 10.7759/cureus.11195. 7. Richardson JM et al. Clinical Relevance of Reapplication of Blood Samples During Blood Glucose Testing. Poster presented at the 20th Annual Diabetes Technology Meeting (DTM); November 12-14, 2020. 8. Harrison B and Brown D. Expert Rev Med Devices. 2020 Jan 10; 17(1): 75‐82. 9. Fisher W et al. User Experience With the Information–Motivation–Behavioral Skills (IMB)–Based CONTOUR®NEXT ONE Smart Meter and App System. Poster presented at the 78th Scientific Session of the American Diabetes Association (ADA); June 22‐26, 2018; Orlando, Florida. 10. Grady M et al. J Diabetes Sci Technol. 2018;12:1211-1
Above Target Range
(Amber)
Within Target Range
(Green)
Below Target Range
(Red)
Check to see if your smartphone’s operating system is compatible
ƒ95% of the measured glucose values needed to fall within either ±15 mg/dL (±0.83 mmol/L) of the average measured values of the reference measurement procedure at glucose concentrations <100 mg/dL (<5.55 mmol/L) or within ±15% at glucose concentrations ≥100 mg/dL (≥5.55 mmol/L). 99% of individual glucose measured values need to fall within zones A and B of the Consensus Error Grid (CEG) for type 1 diabetes.3
#Before use see the CONTOUR®NEXT ONE user guide for full instructions. †Always consult your healthcare professional before setting or changing any target ranges. ^On a compatible Android or iOS device. For a full list of compatible mobile operating systems, visit compatibility.contourone.com.
1. CONTOUR®NEXT ONE BGMS User Guide Rev 08/19. 2. Christiansen M et al. J Diabetes Sci Technol 2017;11(3):567-573. 3. International Organization for Standardization. In vitro diagnostic test systems –requirements for blood‐glucose monitoring systems for self‐testing in managing diabetes mellitus (ISO 15197). International Organization for Standardization, Geneva, Switzerland, 2013. 4. Stedman M et al. J Diabetes Sci Technol. 2020 Mar 14; doi: 10.1177/1932296820905880. Online ahead of print. 5. Campos-Nañez E, Breton MD. J Diabetes Sci Technol. 2017;11(6):1196-1206. 6. Al Hayek A et al. 27 Oct 2020. Patient Satisfaction and Clinical Efficacy of Novel Blood Glucose Meters Featuring Color Range Indicators in Patients With Type 2 Diabetes: A Prospective Study. Cureus 12(10): e11195. DOI 10.7759/cureus.11195. 7. Richardson JM et al. Clinical Relevance of Reapplication of Blood Samples During Blood Glucose Testing. Poster presented at the 20th Annual Diabetes Technology Meeting (DTM); November 12-14, 2020. 8. Harrison B and Brown D. Expert Rev Med Devices. 2020 Jan 10; 17(1): 75‐82. 9. Fisher W et al. User Experience With the Information–Motivation–Behavioral Skills (IMB)–Based CONTOUR®NEXT ONE Smart Meter and App System. Poster presented at the 78th Scientific Session of the American Diabetes Association (ADA); June 22‐26, 2018; Orlando, Florida. 10. Grady M et al. J Diabetes Sci Technol. 2018;12:1211-1
CONTOUR®NEXT ONE blood glucose meter allows you 60 seconds to apply more blood to the same strip if the first sample is not enough – no need to remove the test strip.
Check to see if your smartphone’s operating system is compatible
ƒ95% of the measured glucose values needed to fall within either ±15 mg/dL (±0.83 mmol/L) of the average measured values of the reference measurement procedure at glucose concentrations <100 mg/dL (<5.55 mmol/L) or within ±15% at glucose concentrations ≥100 mg/dL (≥5.55 mmol/L). 99% of individual glucose measured values need to fall within zones A and B of the Consensus Error Grid (CEG) for type 1 diabetes.3
#Before use see the CONTOUR®NEXT ONE user guide for full instructions. †Always consult your healthcare professional before setting or changing any target ranges. ^On a compatible Android or iOS device. For a full list of compatible mobile operating systems, visit compatibility.contourone.com.
1. CONTOUR®NEXT ONE BGMS User Guide Rev 08/19. 2. Christiansen M et al. J Diabetes Sci Technol 2017;11(3):567-573. 3. International Organization for Standardization. In vitro diagnostic test systems –requirements for blood‐glucose monitoring systems for self‐testing in managing diabetes mellitus (ISO 15197). International Organization for Standardization, Geneva, Switzerland, 2013. 4. Stedman M et al. J Diabetes Sci Technol. 2020 Mar 14; doi: 10.1177/1932296820905880. Online ahead of print. 5. Campos-Nañez E, Breton MD. J Diabetes Sci Technol. 2017;11(6):1196-1206. 6. Al Hayek A et al. 27 Oct 2020. Patient Satisfaction and Clinical Efficacy of Novel Blood Glucose Meters Featuring Color Range Indicators in Patients With Type 2 Diabetes: A Prospective Study. Cureus 12(10): e11195. DOI 10.7759/cureus.11195. 7. Richardson JM et al. Clinical Relevance of Reapplication of Blood Samples During Blood Glucose Testing. Poster presented at the 20th Annual Diabetes Technology Meeting (DTM); November 12-14, 2020. 8. Harrison B and Brown D. Expert Rev Med Devices. 2020 Jan 10; 17(1): 75‐82. 9. Fisher W et al. User Experience With the Information–Motivation–Behavioral Skills (IMB)–Based CONTOUR®NEXT ONE Smart Meter and App System. Poster presented at the 78th Scientific Session of the American Diabetes Association (ADA); June 22‐26, 2018; Orlando, Florida. 10. Grady M et al. J Diabetes Sci Technol. 2018;12:1211-1
1. Insert the CONTOUR®NEXT test strip with the gray square end facing the meter (this will automatically turn on the meter).
2. Allow the blood drop to sip into the CONTOUR®NEXT test strip.
3. Displays your blood glucose reading within 5 seconds.
Check to see if your smartphone’s operating system is compatible
ƒ95% of the measured glucose values needed to fall within either ±15 mg/dL (±0.83 mmol/L) of the average measured values of the reference measurement procedure at glucose concentrations <100 mg/dL (<5.55 mmol/L) or within ±15% at glucose concentrations ≥100 mg/dL (≥5.55 mmol/L). 99% of individual glucose measured values need to fall within zones A and B of the Consensus Error Grid (CEG) for type 1 diabetes.3
#Before use see the CONTOUR®NEXT ONE user guide for full instructions. †Always consult your healthcare professional before setting or changing any target ranges. ^On a compatible Android or iOS device. For a full list of compatible mobile operating systems, visit compatibility.contourone.com.
1. CONTOUR®NEXT ONE BGMS User Guide Rev 08/19. 2. Christiansen M et al. J Diabetes Sci Technol 2017;11(3):567-573. 3. International Organization for Standardization. In vitro diagnostic test systems –requirements for blood‐glucose monitoring systems for self‐testing in managing diabetes mellitus (ISO 15197). International Organization for Standardization, Geneva, Switzerland, 2013. 4. Stedman M et al. J Diabetes Sci Technol. 2020 Mar 14; doi: 10.1177/1932296820905880. Online ahead of print. 5. Campos-Nañez E, Breton MD. J Diabetes Sci Technol. 2017;11(6):1196-1206. 6. Al Hayek A et al. 27 Oct 2020. Patient Satisfaction and Clinical Efficacy of Novel Blood Glucose Meters Featuring Color Range Indicators in Patients With Type 2 Diabetes: A Prospective Study. Cureus 12(10): e11195. DOI 10.7759/cureus.11195. 7. Richardson JM et al. Clinical Relevance of Reapplication of Blood Samples During Blood Glucose Testing. Poster presented at the 20th Annual Diabetes Technology Meeting (DTM); November 12-14, 2020. 8. Harrison B and Brown D. Expert Rev Med Devices. 2020 Jan 10; 17(1): 75‐82. 9. Fisher W et al. User Experience With the Information–Motivation–Behavioral Skills (IMB)–Based CONTOUR®NEXT ONE Smart Meter and App System. Poster presented at the 78th Scientific Session of the American Diabetes Association (ADA); June 22‐26, 2018; Orlando, Florida. 10. Grady M et al. J Diabetes Sci Technol. 2018;12:1211-1
Have a question about using your CONTOUR®NEXT ONE meter? Check out our frequently asked questions below.
Don’t see what you’re looking for? Feel free to contact us.
There are two ways you can set up your CONTOUR®NEXT ONE meter: on the meter itself, or by using the CONTOUR®DIABETES app.
For instructions on initial setup from the meter itself, please see the User Guide that you received with your meter.
To set up your meter from the app, download the CONTOUR®DIABETES app, open the app, tap ‘Get started’ and follow the instructions. This will set up the meter and app at the same time.
You can switch the meter on by either:
or
Your CONTOUR®NEXT ONE meter should always be used with CONTOUR®NEXT test strips. These have been specifically designed for use with the meter. The CONTOUR®NEXT strips are listed on the NDSS, code 195.
The smartLIGHT® feature on the CONTOUR®NEXT ONE meter gives you instant feedback on your blood glucose readings1. It immediately identifies your readings as above, below or within target range to help you make decisions. This feature can be switched off if you prefer not to use it.
Green = within target
Amber = above target
Red = below target
Second-Chance® sampling is another useful feature of the CONTOUR®NEXT ONE meter1. If your first sample is insufficient to take a blood glucose reading, Second-Chance® sampling lets you apply more blood to the same strip instead of using a new one. This may help you:
The Second-Chance® sampling feature will cause your CONTOUR®NEXT ONE meter to beep twice and display a flashing test strip icon. Within 60 seconds, apply some more blood to the test strip so there is enough for the meter to measure your blood glucose. Once you have added enough blood, the meter will automatically take a reading as usual.
Meter settings cannot be changed from the meter while the meter is connected to the app. To change settings on the meter either:
Or
These symbols are Meal Markers. Meal Markers allow your meter to compare blood glucose readings against the related target ranges, so that the smartLIGHT® feature can indicate whether your blood glucose is above, below or within target range.
You can select the appropriate marker on your meter each time you take a blood glucose reading. There are three variations of the apple symbol:
Fasting Meal Marker
Choose this if you are testing your blood glucose after about 8 hours without eating
Before-meal Meal Marker
Choose this if you are testing your blood glucose within 1 hour before a meal
After-meal Meal Marker
Choose this if you are testing your blood glucose within 2 hours after the first bite of a meal
Check to see if your smartphone’s operating system is compatible
** Before use please see the CONTOUR®NEXT ONE user guide for full instructions.
1. CONTOUR®NEXT ONE BGMS User Guide Rev 08/19.
2. Richardson JM et al. Clinical Relevance of Reapplication of Blood Samples During Blood Glucose Testing. Poster presented at the 20th Annual Diabetes Technology Meeting (DTM); November 12-14, 2020.
Always read instructions for use. Consult your healthcare professional if this product is right for you.
©2024 Ascensia Diabetes Care Holdings AG. All rights reserved.
Ascensia, the Ascensia Diabetes Care logo, Contour, Microlet, Glucofacts, the No Coding logo, smartLIGHT and Second-Chance are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG.
Apple and the Apple logo are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC. The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks by Ascensia Diabetes Care is under license. All other trademarks are the property of their respective owners.
Suite 6, Level 3 25 Solent Circuit Baulkham Hills NSW 2153
Always read instructions for use. Consult your healthcare professional if this product is right for you.
©2024 Ascensia Diabetes Care Holdings AG. All rights reserved.
Ascensia, the Ascensia Diabetes Care logo, Contour, Microlet, Glucofacts, the No Coding logo, smartLIGHT and Second-Chance are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG.
Apple and the Apple logo are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC. The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks by Ascensia Diabetes Care is under license. All other trademarks are the property of their respective owners.
